Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYALURONIDASE \TRASTUZUMAB: 81 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
81
Total FAERS Reports
11 (13.6%)
Deaths Reported
53
Hospitalizations
81
As Primary/Secondary Suspect
4
Life-Threatening
3
Disabilities

First Report: 20130706 · Latest Report: 20250911

What Are the Most Common HYALURONIDASE \TRASTUZUMAB Side Effects?

#1 Most Reported
Diarrhoea
26 reports (32.1%)
#2 Most Reported
Fatigue
21 reports (25.9%)
#3 Most Reported
Ejection fraction decreased
15 reports (18.5%)

All HYALURONIDASE \TRASTUZUMAB Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Diarrhoea 26 32.1% 4 23
Fatigue 21 25.9% 4 17
Ejection fraction decreased 15 18.5% 1 12
Alopecia 13 16.1% 0 9
Anaemia 13 16.1% 0 9
Nausea 13 16.1% 5 11
Lymphoedema 12 14.8% 1 9
Pneumonia 12 14.8% 1 12
Vomiting 12 14.8% 5 8
Epistaxis 10 12.4% 0 7
Gastrooesophageal reflux disease 10 12.4% 1 8
Mucosal inflammation 10 12.4% 1 9
Off label use 10 12.4% 0 7
Rash 10 12.4% 1 7
Influenza like illness 9 11.1% 0 7
Pneumothorax 9 11.1% 1 9
Device related infection 8 9.9% 0 7
Headache 8 9.9% 2 4
Hot flush 8 9.9% 0 7
Hypokalaemia 8 9.9% 1 5

Who Reports HYALURONIDASE \TRASTUZUMAB Side Effects? Age & Gender Data

Gender: 100.0% female, 0.0% male. Average age: 53.7 years. Most reports from: GB. View detailed demographics →

Is HYALURONIDASE \TRASTUZUMAB Getting Safer? Reports by Year

YearReportsDeathsHosp.
2013 1 0 1
2015 22 5 17
2016 5 3 4
2017 5 0 4
2018 8 2 4
2019 11 0 7
2020 5 1 5
2021 3 0 0
2022 15 0 11
2025 1 0 0

View full timeline →

What Is HYALURONIDASE \TRASTUZUMAB Used For?

IndicationReports
Breast cancer metastatic 35
Her2 positive breast cancer 35
Breast cancer 7

Official FDA Label for HYALURONIDASE \TRASTUZUMAB

Official prescribing information from the FDA-approved drug label.